| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
3,010,072 | 2,883,501 | 2,808,332 | 2,748,377 | 2,566,111 |
|
Cost of Revenue
|
-864,417 | -817,800 | -774,554 | -828,675 | -744,592 |
|
Gross Profit
|
2,145,655 | 2,065,701 | 2,033,778 | 1,919,702 | 1,821,519 |
| Selling, General and Administrative Expenses
|
-1,263,086 | -1,247,596 | -1,210,514 | -1,102,438 | -1,022,659 |
|
Research and Development Expenses
|
-461,044 | -450,192 | -443,056 | -469,332 | -412,398 |
|
Operating Income/Expenses
|
-1,724,130 | -1,697,788 | -1,653,570 | -1,571,770 | -1,435,057 |
|
Total Operating Profit/Loss
|
421,525 | 367,913 | 380,208 | 347,932 | 386,462 |
| Total Net Finance Income/Expense
|
33,909 | 25,980 | 17,176 | 21,957 | -3,212 |
| Net Investment Income
|
9,695 | -40,428 | 13,391 | -6,348 | -206 |
| Irregular Income/Expenses
|
0 | -106,800 | 0 | -70,721 | -1,045,022 |
|
Non-Operating Income/Expenses, Total
|
43,604 | -121,248 | 30,567 | -55,112 | -1,048,440 |
|
Pretax Income
|
465,129 | 246,665 | 410,775 | 292,820 | -661,978 |
|
Provision for Income Tax
|
-84,656 | -83,683 | -107,494 | 14,748 | -32,310 |
|
Net Income from Continuing Operations
|
380,473 | 162,982 | 303,281 | 307,568 | -694,288 |
|
Discontinued Operations
|
543,909 | -- | -- | -- | -- |
|
Net Income after Extraordinary Items and Discontinued Operations
|
987,282 | 162,982 | 303,281 | 307,568 | -694,288 |
|
Net Income after Non-Controlling/Minority Interests
|
987,282 | 162,982 | 303,281 | 307,568 | -694,288 |
|
Net Income Available to Common Stockholders
|
987,282 | 162,982 | 303,281 | 307,568 | -694,288 |
|
Dilution to Earnings
|
17,876 | 10,125 | 6,325 | 6,336 | 0 |
|
Diluted Net Income Available to Common Stockholders
|
1,005,158 | 173,107 | 309,606 | 313,904 | -694,288 |
| Basic EPS
|
10.43 | 1.59 | 2.64 | 2.51 | -5.48 |
| Diluted EPS
|
8.28 | 1.39 | 2.35 | 2.24 | -5.48 |
|
Basic Weighted Average Shares Outstanding
|
95,315.75 | 102,356 | 114,944 | 122,503 | 126,779 |
|
Diluted Weighted Average Shares Outstanding
|
121,426.75 | 124,114 | 131,721 | 140,145 | 126,779 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
431,220 | 220,685 | 393,599 | 270,863 | -658,766 |
|
EBITDA
|
534,582 | 322,530 | 501,673 | 362,186 | -562,064 |
|
Normalized EBITDA
|
812,894 | 734,511 | 781,538 | 754,311 | 716,882 |
|
Normalized Income
|
652,109.51 | 395,353.25 | 512,110.90 | 588,238.41 | 1,358,702.90 |
|
Total Unusual Items
|
332,076 | 351,545 | 282,847 | 355,279 | 2,320,932 |
12/31/2022 - 4/16/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade